Victoria Ruschil
Overview
Explore the profile of Victoria Ruschil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruscheweyh R, Gaul C, Dresler T, Patrick Jurgens T, Lewis D, Kraya T, et al.
Schmerz
. 2025 Feb;
PMID: 39948245
To enable state-of-the-art diagnosis, therapy and monitoring of headache disorders, comprehensive history taking is necessary and can be time-consuming. This is facilitated substantially if the patient gathers the needed information...
2.
Ruscheweyh R, Forderreuther S, Freilinger T, Gaul C, Gossrau G, Patrick Jurgens T, et al.
Cephalalgia
. 2024 Jul;
44(7):3331024241261077.
PMID: 39033424
Background: The Migraine Disability Assessment (MIDAS) is widely used. However, there are limited data on how much a reduction in the MIDAS score indicates a change that matters to the...
3.
Ruscheweyh R, Gossrau G, Dresler T, Freilinger T, Forderreuther S, Gaul C, et al.
J Headache Pain
. 2023 Oct;
24(1):135.
PMID: 37817093
Background: Triptans are effective for many migraine patients, but some do not experience adequate efficacy and tolerability. The European Headache Federation (EHF) has proposed that patients with lack of efficacy...
4.
Ruscheweyh R, Dresler T, Forderreuther S, Gaul C, Gossrau G, Patrick Jurgens T, et al.
Cephalalgia
. 2023 May;
43(5):3331024231174855.
PMID: 37177799
Background: Most migraine patients need an effective acute medication. Real-world data can provide important information on the performance of acute migraine medication in clinical practice. Methods: We used data from...
5.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Schmerz
. 2023 Jan;
37(1):17-18.
PMID: 36662297
No abstract available.
6.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Nervenarzt
. 2023 Jan;
94(4):318-319.
PMID: 36645452
No abstract available.
7.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Schmerz
. 2022 Oct;
37(1):5-16.
PMID: 36287263
Migraine is the most common neurological disorder and can be associated with a high degree of disability. In addition to non-pharmacological approaches to reduce migraine frequency, pharmacological migraine preventatives are...
8.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Nervenarzt
. 2022 Oct;
94(4):306-317.
PMID: 36287216
Migraine is the most common neurological disorder and can be associated with a high degree of disability. In addition to non-pharmacological approaches to reduce migraine frequency, pharmacological migraine preventatives are...
9.
Laske C, Muller S, Preische O, Ruschil V, Munk M, Honold I, et al.
Front Neurosci
. 2022 May;
16:792996.
PMID: 35516807
Background: Changes in intestinal microbiome composition have been described in animal models of Alzheimer's disease (AD) and AD patients. Here we investigated how well taxonomic and functional intestinal microbiome data...
10.
Ruschil V, Mazurak N, Hofmann M, Loskutova E, Enck P, Freilinger T, et al.
Front Neurol
. 2021 Sep;
12:713391.
PMID: 34557148
Up to 48% of patients with medically unexplained symptoms seen in neurological practice suffer from sensory symptoms, which could be of functional nature or secondary to psychiatric disorders. These patients...